{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:07:21Z","timestamp":1791270441160,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK074970"],"award-info":[{"award-number":["DK074970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HD044405"],"award-info":[{"award-number":["HD044405"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"crossref","award":["7-13-BS-101"],"award-info":[{"award-number":["7-13-BS-101"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.biochi.2015.06.018","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T14:11:45Z","timestamp":1435846305000},"page":"92-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Effect of selective estrogen receptor modulators on metabolic homeostasis"],"prefix":"10.1016","volume":"124","author":[{"given":"Beibei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Lovre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Mauvais-Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biochi.2015.06.018_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1034\/j.1600-0463.2001.090503.x","article-title":"Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER alpha and ER beta mRNA with real-time RT-PCR","volume":"109","author":"Pfaffl","year":"2001","journal-title":"APMIS"},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib2","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1091\/mbc.e03-06-0360","article-title":"Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta","volume":"15","author":"Tee","year":"2004","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1096-7192(02)00043-4","article-title":"Effects of selective estrogen receptor modulators (SERMs) on coactivator nuclear receptor (NR) box binding to estrogen receptors","volume":"76","author":"Bramlett","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib5","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1074\/jbc.M208501200","article-title":"Differential SERM effects on corepressor binding dictate ERalpha activity in\u00a0vivo","volume":"278","author":"Webb","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"issue":"9114","key":"10.1016\/j.biochi.2015.06.018_bib6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"8630","key":"10.1016\/j.biochi.2015.06.018_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(89)91141-0","article-title":"Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers","volume":"1","author":"Fornander","year":"1989","journal-title":"Lancet"},{"issue":"8895","key":"10.1016\/j.biochi.2015.06.018_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0140-6736(94)92692-1","article-title":"Risk of endometrial cancer after tamoxifen treatment of breast cancer","volume":"343","author":"van Leeuwen","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biochi.2015.06.018_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2217\/17455057.3.2.139","article-title":"Raloxifene: a selective estrogen receptor modulator for reducing the risk of invasive breast cancer in postmenopausal women","volume":"3","author":"Vogel","year":"2007","journal-title":"Womens Health (Lond Engl)"},{"issue":"7","key":"10.1016\/j.biochi.2015.06.018_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.biochi.2015.06.018_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/1759720X11422602","article-title":"Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis","volume":"4","author":"Komm","year":"2012","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"6","key":"10.1016\/j.biochi.2015.06.018_bib12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/gme.0b013e3181a818db","article-title":"Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women","volume":"16","author":"Archer","year":"2009","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.biochi.2015.06.018_bib13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/gme.0b013e3181a7df0d","article-title":"Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene\/conjugated estrogens: a randomized, controlled trial","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"issue":"23","key":"10.1016\/j.biochi.2015.06.018_bib14","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1002\/cncr.27517","article-title":"Association between tamoxifen treatment and diabetes: a population-based study","volume":"118","author":"Hejazi","year":"2012","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib15","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/bjc.2014.488","article-title":"Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer","volume":"111","author":"Sun","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.biochi.2015.06.018_bib16","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/cncr.26559","article-title":"Association between tamoxifen treatment and diabetes: a population-based study","volume":"118","author":"Lipscombe","year":"2012","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.biochi.2015.06.018_bib17","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1158\/0008-5472.CAN-08-0553","article-title":"Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer","volume":"68","author":"Johansson","year":"2008","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.biochi.2015.06.018_bib18","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.0602956103","article-title":"Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice","volume":"103","author":"Le May","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biochi.2015.06.018_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11892-010-0124-4","article-title":"Management of hypertriglyceridemia in the diabetic patient","volume":"10","author":"Jialal","year":"2010","journal-title":"Curr. Diab Rep."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib20","first-page":"341","article-title":"Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with diabetes mellitus","volume":"26","author":"Kim","year":"2014","journal-title":"Chin. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/joc.2002.14.3.309","article-title":"Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer","volume":"14","author":"Artac","year":"2002","journal-title":"J.\u00a0Chemother."},{"issue":"5","key":"10.1016\/j.biochi.2015.06.018_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1507\/endocrj.44.745","article-title":"Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery","volume":"44","author":"Hozumi","year":"1997","journal-title":"Endocr. J."},{"issue":"8","key":"10.1016\/j.biochi.2015.06.018_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1023\/A:1008309613082","article-title":"Tamoxifen-induced severe hypertriglyceridemia and pancreatitis","volume":"11","author":"Elisaf","year":"2000","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.biochi.2015.06.018_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.cad.0000215056.47695.92","article-title":"Fatty liver and transaminase changes with adjuvant tamoxifen therapy","volume":"17","author":"Liu","year":"2006","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.biochi.2015.06.018_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2214\/ajr.180.1.1800129","article-title":"Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy","volume":"180","author":"Nishino","year":"2003","journal-title":"AJR Am. J. Roentgenol."},{"issue":"9104","key":"10.1016\/j.biochi.2015.06.018_bib26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(05)78493-2","article-title":"Tamoxifen-induced fatty liver in patients with breast cancer","volume":"351","author":"Ogawa","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biochi.2015.06.018_bib27","first-page":"61","article-title":"Tamoxifen therapy and hepatic steatosis","volume":"49","author":"Coskun","year":"2002","journal-title":"Neoplasma"},{"issue":"7497","key":"10.1016\/j.biochi.2015.06.018_bib28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"Bruno","year":"2005","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.biochi.2015.06.018_bib29","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1194\/jlr.M600148-JLR200","article-title":"Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver","volume":"47","author":"Gudbrandsen","year":"2006","journal-title":"J.\u00a0Lipid Res."},{"issue":"4","key":"10.1016\/j.biochi.2015.06.018_bib30","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/hep.23813","article-title":"Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis","volume":"52","author":"Cole","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib31","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1096\/fj.04-3196com","article-title":"Transcript and metabolite analysis of the effects of tamoxifen in rat liver reveals inhibition of fatty acid synthesis in the presence of hepatic steatosis","volume":"19","author":"Lelliott","year":"2005","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/eje.0.1430427","article-title":"In\u00a0vitro study of the effect of raloxifene on lipid metabolism compared with tamoxifen","volume":"143","author":"Hozumi","year":"2000","journal-title":"Eur. J. Endocrinol."},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib33","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1872-034X.2009.00512.x","article-title":"Effects of estrogen and androgen deprivation on the progression of non-alcoholic steatohepatitis (NASH) in male Sprague\u2013Dawley rats","volume":"39","author":"Mu","year":"2009","journal-title":"Hepatol. Res."},{"issue":"5","key":"10.1016\/j.biochi.2015.06.018_bib34","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2131\/jts.37.931","article-title":"Hepatoprotective effect of tamoxifen on steatosis and non-alcoholic steatohepatitis in mouse models","volume":"37","author":"Miyashita","year":"2012","journal-title":"J.\u00a0Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.biochi.2015.06.018_bib35","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.taap.2012.06.023","article-title":"Mechanisms of the hepatoprotective effects of tamoxifen against drug-induced and chemical-induced acute liver injuries","volume":"264","author":"Yoshikawa","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biochi.2015.06.018_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tox.2014.08.004","article-title":"Genotoxic, epigenetic, and transcriptomic effects of tamoxifen in mouse liver","volume":"325","author":"de Conti","year":"2014","journal-title":"Toxicology"},{"issue":"6 Pt 2","key":"10.1016\/j.biochi.2015.06.018_bib37","first-page":"R1219","article-title":"Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats","volume":"264","author":"Wade","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib38","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1093\/jn\/131.9.2351","article-title":"Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats","volume":"131","author":"Wallen","year":"2001","journal-title":"J.\u00a0Nutr."},{"issue":"5","key":"10.1016\/j.biochi.2015.06.018_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib40","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jjco\/hye097","article-title":"Effects of tamoxifen on the serum leptin level in patients with breast cancer","volume":"31","author":"Ozet","year":"2001","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biochi.2015.06.018_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1185\/030079902125001308","article-title":"Serum leptin levels are associated with tamoxifen-induced hepatic steatosis","volume":"19","author":"Gunel","year":"2003","journal-title":"Curr. Med. Res. Opin."},{"issue":"5","key":"10.1016\/j.biochi.2015.06.018_bib42","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/db05-1356","article-title":"Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA","volume":"55","author":"Lopez","year":"2006","journal-title":"Diabetes"},{"issue":"23","key":"10.1016\/j.biochi.2015.06.018_bib43","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.biochi.2015.06.018_bib44","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.10.8.8666168","article-title":"Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats","volume":"10","author":"Sato","year":"1996","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.biochi.2015.06.018_bib45","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1210\/en.2004-0129","article-title":"Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats","volume":"145","author":"Meli","year":"2004","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.biochi.2015.06.018_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF03347261","article-title":"Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women","volume":"28","author":"Francucci","year":"2005","journal-title":"J.\u00a0Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.biochi.2015.06.018_bib47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-09-0619","article-title":"Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial","volume":"162","author":"Jacobsen","year":"2010","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.biochi.2015.06.018_bib48","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/oby.20653","article-title":"Estrogen or raloxifene during postmenopausal weight loss: adiposity and cardiometabolic outcomes","volume":"22","author":"Van Pelt","year":"2014","journal-title":"Obes. (Silver Spring)"},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib49","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2001-011302","article-title":"The effect of raloxifene on glyco-insulinemic homeostasis in healthy postmenopausal women: a randomized placebo-controlled study","volume":"87","author":"Cucinelli","year":"2002","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib50","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1210\/jc.2002-020120","article-title":"Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women","volume":"87","author":"Cagnacci","year":"2002","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib51","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.fertnstert.2007.03.083","article-title":"Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women","volume":"89","author":"Nagamani","year":"2008","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.biochi.2015.06.018_bib52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1210\/jcem.87.1.8168","article-title":"Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial","volume":"87","author":"Andersson","year":"2002","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib53","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00125-004-1328-4","article-title":"Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women","volume":"47","author":"Lasco","year":"2004","journal-title":"Diabetologia"},{"issue":"17","key":"10.1016\/j.biochi.2015.06.018_bib54","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins","volume":"325","author":"Walsh","year":"1991","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0149-2918(03)80114-5","article-title":"Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes","volume":"25","author":"Barrett-Connor","year":"2003","journal-title":"Clin. Ther."},{"issue":"9","key":"10.1016\/j.biochi.2015.06.018_bib56","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0149-2918(01)80127-2","article-title":"Effect of raloxifene on serum triglycerides in postmenopausal women: influence of predisposing factors for hypertriglyceridemia","volume":"23","author":"Mosca","year":"2001","journal-title":"Clin. Ther."},{"issue":"7","key":"10.1016\/j.biochi.2015.06.018_bib57","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2337\/diacare.28.7.1555","article-title":"Effect of raloxifene on serum triglycerides in women with a history of hypertriglyceridemia while on oral estrogen therapy","volume":"28","author":"Carr","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.biochi.2015.06.018_bib58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/isl.19747","article-title":"Selective estrogen receptor modulation in pancreatic beta-cells and the prevention of type 2 diabetes","volume":"4","author":"Tiano","year":"2012","journal-title":"Islets"},{"issue":"2","key":"10.1016\/j.biochi.2015.06.018_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajog.2005.01.023","article-title":"Raloxifene increases serum leptin levels in postmenopausal women: a prospective study","volume":"193","author":"Cakmak","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.biochi.2015.06.018_bib60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.maturitas.2007.10.003","article-title":"Circulating leptin and ghrelin are differentially influenced by estrogen\/progestin therapy and raloxifene","volume":"59","author":"Lambrinoudaki","year":"2008","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.biochi.2015.06.018_bib61","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/01.gme.0000227335.27996.d8","article-title":"Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene","volume":"13","author":"Tommaselli","year":"2006","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.biochi.2015.06.018_bib62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00042192-200310020-00008","article-title":"Effects of bilateral ovariectomy and postoperative hormonal replacement therapy with 17beta-estradiol or raloxifene on serum leptin levels","volume":"10","author":"Tommaselli","year":"2003","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.biochi.2015.06.018_bib63","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/jcp.24324","article-title":"Evolution of the tissue selective estrogen complex (TSEC)","volume":"228","author":"Komm","year":"2013","journal-title":"J.\u00a0Cell. Physiol."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/jc.2013-3680","article-title":"Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women","volume":"99","author":"Santen","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2015.06.018_bib65","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","author":"Lobo","year":"2009","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.biochi.2015.06.018_bib66","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/GME.0000000000000362","article-title":"Effects of conjugated estrogens\/bazedoxifene on lipid and coagulation variables: a randomized placebo- and active-controlled trial","volume":"22","author":"Skouby","year":"2015","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.biochi.2015.06.018_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmet.2013.12.009","article-title":"Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice","volume":"3","author":"Kim","year":"2014","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib68","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1152\/ajpendo.00653.2013","article-title":"Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract","volume":"307","author":"Barrera","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.biochi.2015.06.018_bib69","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1210\/en.2013-1731","article-title":"Estrogen replacement therapy regulation of energy metabolism in female mouse hypothalamus","volume":"155","author":"Fontana","year":"2014","journal-title":"Endocrinology"},{"issue":"29","key":"10.1016\/j.biochi.2015.06.018_bib70","doi-asserted-by":"crossref","first-page":"11806","DOI":"10.1073\/pnas.1205797109","article-title":"Tetradian oscillation of estrogen receptor alpha is necessary to prevent liver lipid deposition","volume":"109","author":"Villa","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.biochi.2015.06.018_bib71","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biochi.2015.06.018_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2012-1055","article-title":"The role of estrogens in control of energy balance and glucose homeostasis","volume":"34","author":"Mauvais-Jarvis","year":"2013","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.biochi.2015.06.018_bib73","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.maturitas.2013.02.001","article-title":"Global Consensus Statement on menopausal hormone therapy","volume":"74","author":"de Villiers","year":"2013","journal-title":"Maturitas"},{"issue":"7","key":"10.1016\/j.biochi.2015.06.018_bib74","doi-asserted-by":"crossref","first-page":"E759","DOI":"10.1152\/ajpendo.00327.2011","article-title":"Selective estrogen receptor modulator promotes weight loss in ovariectomized female rhesus monkeys (Macaca mulatta) by decreasing food intake and increasing activity","volume":"302","author":"Sullivan","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2015.06.018_bib75","series-title":"Pilot Study of Duavee in Preventing Metabolic Dysfunction in Postmenopausal Women","author":"Mauvais-Jarvis","year":"2014"},{"key":"10.1016\/j.biochi.2015.06.018_bib76","series-title":"Tissue Selective Estrogen Complex to Prevent Metabolic Dysfunction in Women (TSEC)","author":"Ravussin","year":"2014"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908415001972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908415001972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T19:00:52Z","timestamp":1566932452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908415001972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":76,"alternative-id":["S0300908415001972"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2015.06.018","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of selective estrogen receptor modulators on metabolic homeostasis","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2015.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}